MMP7 cleaves remyelination‐impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions
Open Access
Abstract
Upon demyelination, transient expression of fibronectin precedes successful remyelination. However, in chronic demyelination observed in multiple sclerosis (MS), aggregates of fibronectin persist and contribute to remyelination failure. Accordingly, removing fibronectin (aggregates) would constitute an effective strategy for promoting remyelination. Matrix metalloproteinases (MMPs) are enzymes known to remodel extracellular matrix components, including fibronectin. Here, we examined the ability of MMPs to degrade fibronectin aggregates. Our findings reveal that MMP7 cleaved fibronectin aggregates resulting into a prominent 13 kDa EIIIA (16 kDa EDA)‐containing fragment. MMP7 was upregulated during lysolecithin‐induced demyelination, indicating its potential for endogenous fibronectin clearance. In contrast, the expression of proMMP7 was substantially decreased in chronic active and inactive MS lesions compared with control white matter and remyelinated MS lesions. Microglia and macrophages were major cellular sources of proMMP7 and IL‐4‐activated, but not IFNγ+LPS‐activated, microglia and macrophages secreted significant levels of proMMP7. Also, conditioned medium of IL‐4‐activated macrophages most efficiently cleaved fibronectin aggregates upon MMP‐activating conditions. Yet, coatings of MMP7‐cleaved fibronectin aggregate fragments inhibited oligodendrocyte maturation, indicating that further degradation and/or clearance by phagocytosis is essential. These findings suggest that MMP7 cleaves fibronectin aggregates, while reduced (pro)MMP7 levels in MS lesions contribute to their persistent presence. Therefore, upregulating MMP7 levels may be key to remove remyelination‐impairing fibronectin aggregates in MS lesions.Keywords
Funding Information
- Stichting MS Research
- China Scholarship Council
This publication has 71 references indexed in Scilit:
- M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelinationNature Neuroscience, 2013
- Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation statusJournal of Neuroinflammation, 2013
- Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for RemyelinationASN Neuro, 2012
- Glycolytic oligodendrocytes maintain myelin and long-term axonal integrityNature, 2012
- Extracellular Matrix Degradation and Remodeling in Development and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2Proceedings of the National Academy of Sciences, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitisBMC Neuroscience, 2009
- Multiple sclerosisThe Lancet, 2008
- Astrocytes in multiple sclerosis: A product of their environmentCellular and Molecular Life Sciences, 2008